To this end, in this work, we have exploited two murine models of ROS1-positive NSCLC, the KL-ROS1 cell line and the transgenic K-RasG12D mice, to test the efficacy of DNA electrovaccination against ROS1. This evidence concerns the gene ROS1 and non-small cell lung carcinoma.